News from apotex inc

May 10, 2013, 19:11 ET
Apr 26, 2013, 18:24 ET

Voluntary Nationwide Recall of 15 Lots of Piperacillin and Tazobactam for Injection, USP 40.5 Grams due to Possibility of Precipitation / Crystallization in IV Bag or IV Line Upon Reconstitution

WESTON, FL, April 26, 2013 /PRNewswire/ - Apotex Corp. announced today that it is conducting, on behalf of the manufacturer Hospira, Inc., a...

May 11, 2011, 14:48 ET

APOTEX RESUMES SHIPPING TO THE U.S.

- FDA's decision to lift import alert paves the way for Apotex's oral solid dose products to be available again for US consumers;  Company...

May 10, 2011, 13:39 ET

Apotex reanuda los envíos a Estados Unidos

Apotex, uno de los mayores fabricantes farmacéuticos de genéricos del mundo, anunció que pronto reanudará los envíos de...

May 10, 2011, 10:29 ET

APOTEX RESUMES SHIPPING TO THE U.S.

- FDA's decision to lift import alert paves the way for Apotex's oral solid dose products to be available again for US consumers;  Company...

Oct 20, 2009, 10:00 ET

Apotex to Distribute Important Transdermal System for Management of Chronic Pain in the U.S. Market

WESTON, FL, Oct. 20 /PRNewswire/ - Apotex Corp announced today that it has signed an exclusive distribution agreement with Hisamitsu Pharmaceutical...

Sep 08, 2009, 17:25 ET

FDA pharmaceutical import alert

TORONTO, Sept. 8 /PRNewswire/ - Apotex today issued the following statement concerning an Import Alert issued by the US Food and Drug...

May 07, 2008, 01:00 ET

Canadian Company Receives Final Tender Approval From Rwanda For Vital AIDS Drug

TORONTO, May 7 /PRNewswire/ - Apotex Inc., Canada's largest generic pharmaceutical company has successfully bid and been awarded a tender from...

Sep 21, 2007, 01:00 ET

Life Saving AIDS Drug for Africa Gets Final Clearance

TORONTO, Sept. 21 /PRNewswire/ - The Federal Commissioner of Patents issued today a compulsory licence for ApoTriavir under Canada's Access to...

May 12, 2004, 01:00 ET

European Agency Extends Marketing Authorization of Ferriprox(R) (Deferiprone) - Positive Decision Benefits Patients Inadequately Treated by Deferoxamine

LONDON, England, May 12 /PRNewswire/ - The European Commission has just adopted the decision of the European Agency for the Evaluation of...

Dec 18, 2003, 00:00 ET

European Court Rules Against Blood Doctor, Nancy Olivieri, in her Challenge of the Marketing Authorization of Ferriprox(TM) (Deferiprone).

LUXEMBOURG, Dec. 18 /PRNewswire/ - The Court of Justice of the European Communities, Court of First Instance dismissed as inadmissible the case...

Sep 22, 2003, 01:00 ET

Study Confirms Safety and Efficacy of Deferiprone

TORONTO, Sept. 22 /PRNewswire/ - A new study published in Blood reports impressive results from a large, long-term prospective study examining...

May 07, 2003, 01:00 ET

New Hope For Patients Afflicted with Rare Genetic Blood Disease: Study Finds Deferiprone Provides Significantly Greater Cardiac Protection

TORONTO, May 7 /PRNewswire/ - Iron-induced heart disease is the major cause of death in patients with the genetic blood disorder, thalassemia....

Aug 15, 2002, 01:00 ET

Court of Appeals Victory for Apotex Generic Version of Depakote(R)

WESTON, Fla., Aug. 15 /PRNewswire/ -- Apotex Corp. today announced that the Court of Appeals for the Federal Circuit reversed a summary judgment...

May 14, 2002, 01:00 ET

Apotex Announces FDA Approval of Cyclosporine Capsules - The Only Generic Alternative to Novartis Pharmaceutical's Sandimmune(R)

WESTON, Fla., May 14 /PRNewswire/ -- Apotex Corp. today announced the approval by the United States Food and Drug Administration (FDA) of the...

Jun 07, 2001, 01:00 ET

FDA Grants Apotex Tentative Approval For Divalproex Sodium Delayed-Release Tablets; Generic Alternative to Depakote(R) Will be Apotex Exclusive When Available

WESTON, Fla., June 7 /PRNewswire/ -- Apotex Corp. today announced that the Food and Drug Administration (FDA) has granted tentative approval for...

May 30, 2001, 01:00 ET

Apotex Receives Tentative FDA Approval for Generic of GlaxoSmithKline's Paxil(R)

WESTON, Fla., May 30 /PRNewswire/ -- Apotex Corp. today announced that it has received tentative approval from the Food and Drug Administration...

May 11, 2001, 01:00 ET

Apotex Seeks Injunction Against GlaxoSmithKline And Food and Drug Administration (FDA) on Paxil(R); Apotex Seeks Removal of Six Patents For Blockbuster Anti-Depressant from FDA's Orange Book

WESTON, Fla., May 11 /PRNewswire/ -- Apotex Corp. today announced that it has filed an application for an injunction against GlaxoSmithKline...

Dec 01, 2000, 00:00 ET

Apotex Corp. Comments on FDA's Dismissal of Citizen's Petition; Dismissal Opens Door to Apotex's Court Case Regarding Paroxetine Patent Infringement

WESTON, Fla., Dec. 1 /PRNewswire/ -- Apotex Corp. ("Apotex") today commented on the Food and Drug Administration's (FDA) decision released on...

Aug 25, 1997, 01:00 ET

U.S. Court Dismisses Patent Infringement Case on Apotex's Ranitidine

subsidiary of Apotex Inc., from marketing generic ranitidine tablets, which Glaxo-Wellcome sells under its Zantac(R) brandname. Glaxo...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge